Most supply chain problems that
land on my desk aren’t broken.
They’re stuck.

A negotiation that stopped moving. A supplier relationship that soured. An API sourcing situation with no obvious path forward. An inherited supply chain that nobody has properly looked at since the acquisition.

I’ve spent thirty years in pharmaceutical procurement and supply chain — in Europe, Asia, and the US — unlocking exactly these kinds of situations. Not by winning something for one side, but by finding the point where things can move again.

If something in your world has stopped moving, let’s talk.

01What I do

Where I get called in

Here is where I tend to get called in:

A key supplier has become unreliable — or has simply stopped cooperating — and the usual levers aren’t working. The relationship has history, but something shifted, and now supply is at risk.

An API sourcing situation has no obvious solution. The molecule is difficult, the market is thin, the obvious suppliers have already been tried. Someone needs to find a different angle.

A supply chain was inherited — through an acquisition, a product transfer, or a change in ownership — and nobody has properly assessed what’s actually there. It looks functional until it doesn’t.

A negotiation has stalled. Positions have hardened. The conversation stopped moving because neither side can see past their own corner of the problem.

A procurement function needs to be built, rebuilt, or significantly upgraded — across a site, a region, or a global operation.

These situations have one thing in common: conventional approaches have reached their limits. That’s usually when I get the call.

02Work

What I’ve done that might be relevant

1

An oncology API with a compromised main supplier and a second one that had significantly raised its price. Renegotiated the second supplier’s agreement, identified and qualified two additional sources, and reduced API cost to approximately 35% of the original baseline — while keeping the launch timeline intact.

2

A CMO-manufactured product at risk of discontinuation due to uncompetitive pricing. The actual problem wasn’t the CMO — it was the API behind it, single-sourced with no leverage. Brought in two alternative API suppliers, reduced the CMO’s API cost by 40% within one year. Product saved.

3

A supply chain inherited from an innovator following an acquisition. Screened alternative API sources, substituted excipients, switched primary packaging — reducing raw material costs to approximately 60% of the innovator’s baseline, bringing manufacturing fully in-house and eliminating the CMO entirely.

4

A critical API supply relationship at risk of causing a stockout for a newly launched product. The root cause wasn’t operational — the supplier felt treated as a tool rather than a partner. Two weeks of daily calls and one week on-site. Supply normalized. Zero additional cost beyond travel.

5

A generic API that had been declared commercially unviable — the originator had deliberately priced its finished product below the threshold any conventional manufacturer could match. Found a fermentation-based process that delivered the API at 60% of the originator’s price. Three years of development. The API is in commercial use today.

03About

Who I am

Mihai Dimitriu

I’m Mihai Dimitriu, a pharmaceutical procurement and supply chain executive with thirty years of experience across Europe, Asia, and the US.

I’ve built procurement functions from scratch, managed global spend portfolios up to $600M, and worked across three continents — in multinational corporations and as an independent advisor.

I’m based in Bucharest, Romania. I’m an EU citizen with no work permit requirements within the EEA, and I’m open to working on-site, remotely, or a combination of both.

I don’t have a methodology with a name. What I have is thirty years of spotting what questions to ask, what to look for when something doesn’t add up, and how to move things that have stopped moving.

If you want to know more before reaching out, my LinkedIn profile is the best place to start: linkedin.com/in/mihai-dimitriu-8170a316

04Contact

Let’s talk

If something in your pharmaceutical supply chain has stopped moving — or if you’re not sure yet whether it should be moving faster — I’m happy to have an initial conversation.

No commitment, no proposal, no pitch. Just a conversation to understand whether what you’re dealing with is something I can help with.

The best way to reach me is by email: mihai_dimitriu@lantaris.eu

Or find me on LinkedIn: linkedin.com/in/mihai-dimitriu-8170a316

Or write to me directly from here